Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite ...

According to Towards Healthcare research, the global polyclonal antibodies market size is calculated at USD 1.76 billion in ...

After 40 years of donating to Canadian Blood Services, 18 years of volunteer firefighting in Collingwood, and 30 years of ...

We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...

Same-arm booster shots trigger a stronger early immune response than shots given in the opposite arm, leading to higher ...